High cost diseases in users of a health insurance company

Authors

  • Inés Milena David D University of Antioquia
  • Ana María Medina P
  • Elkin Martínez L

DOI:

https://doi.org/10.17533/udea.rfnsp.941

Keywords:

High cost, chronic diseases, health investment

Abstract

Introduction: high cost diseases (HCD) present an important risk for financial balance in companies providing health services and it could be a determinant factor for their survival in the market. Materials and methods: all bills and accounts related to hcd of 8,347 users of a health insurance company were reviewed (1999-2003). Results: up to 245 cases of hcdwere reported with a cost of cop $3,520,000,000. In the last year HCD consumed 36% of the total expenses of health services. Hearth diseases, cancer and renal failure represented 65% of that cost. 30% of that budget was spent on people who died while receiving attention. Age and chronicity are linked to death event. Conclusions: HCD really are a significant load for the health system. Patient care is technically impressive and expensive but often applied very late when benefits are rarely possible. It is evident that prevention and health pro-motion is the appropriate option, if not for human and social reasons at least for economic matters.

|Abstract
= 328 veces | PDF (ESPAÑOL (ESPAÑA))
= 32 veces|

Downloads

Download data is not yet available.

References

(1). Norman G, Streiner D. Bioestadística. Madrid: Mosby/Doyma; 1996.

(2). Hallgreen B. Diet and prevention of coronary heart disease and cancer. Estocolmo: Raven Dress; 1986.

(3). Fung T, Willet W, Stamper M, et al. Dietary patterns and the risk of coronary heart desease in women. Arch of Int Medicine 2001;161(15):1857-1862. DOI: https://doi.org/10.1001/archinte.161.15.1857

(4). Hu F, Stampler M, Manson J, et al. Trends in the incidence of coronary heart desease and changes in diet and lifestyle. N Engl J Med 2000;343(8):530-537. DOI: https://doi.org/10.1056/NEJM200008243430802

(5). Colombia. Ministerio de Salud. Situación de salud en Colombia: indicadores básicos. Bogotá: El Ministerio; 2002.

(6). OPS/OMS. La salud en las Américas. Washington D. C.: OPS/OMS; 2002. Publicación Científica: 587.

(7). OPS/OMS. Situación de salud en las Américas: indi-cadores básicos 2002. Washington DC: OPS/OMS; 2002. p.1-12.

(8). OPS/OMS. Análisis de la situación de salud de las Américas. Boletín Epidemiológico OPS 2000;2(4):1-16.

(9). Goldman R, Cook B. The decline in ischemic heart desease mortality rates. An int Med 1984;101:825. DOI: https://doi.org/10.7326/0003-4819-101-6-825

(10). Banco Mundial. Informe sobre el desarrollo mundial: Invertir en salud. Washington: Banco Mundial;1993.

(11). Fries J. Reducing Health care coast by reducing the need and demand for medical services. The New England Journal of Medicine 1993;329(5):321-325. DOI: https://doi.org/10.1056/NEJM199307293290506

(12). Cunningham S. An introduction to economic eva-luation of health care. British Orthodontic Society Londres 2001;28(3):246-250. DOI: https://doi.org/10.1093/ortho/28.3.246

(13). Estados Unidos. Department of Health and Human Services. Healthy People 2000: National health promotion and desease prevention objectives. Washington, D.C.: DHHS Pub N.o(PHS) 1999; 99-1256.

(14). Del Bosque S, González M, Del Bosque M. Manos a la Salud. México: CIESS/OPS. Ed Piensa; 1998.

(15). US Dept Of Health-CDC. Promoting physical activity: A guide for community action. Champaing: Human Kinetics; 2002.

Published

2009-03-20

How to Cite

1.
David D IM, Medina P AM, Martínez L E. High cost diseases in users of a health insurance company. Rev. Fac. Nac. Salud Pública [Internet]. 2009 Mar. 20 [cited 2025 Jan. 22];24(2):1-7. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/941

Issue

Section

Research

Similar Articles

You may also start an advanced similarity search for this article.